From The Straits Times · · 50s
TL;DR: US FDA rejects lung cancer drug from China
US FDA rejects Chinese lung cancer drug after trial shows no life extension.
US FDA rejected ivonescimab, a lung cancer drug invented by China's Akeso Biopharma, after clinical trials failed to show statistically significant life extension. US FDA rejects Chinese lung cancer drug after trial shows no life extension. US FDA rejected ivonescimab, a lung cancer drug invented by China's Akeso Biopharma and licensed by Summit Therapeutics, after clinical trials failed to show statistically significant life extension.
- FDA rejection
- Drug development setback
- Market impact
Read the story version — the same reporting as a swipeable deck of 3 cards.





